Citi Pharma Limited (PSX:CPHL)
60.74
+2.49 (4.27%)
At close: Oct 30, 2026
| Market Cap | 13.88B -28.0% |
| Revenue (ttm) | 14.08B +7.0% |
| Net Income | 790.33M -11.4% |
| EPS | 3.46 -11.4% |
| Shares Out | 228.46M |
| PE Ratio | 17.56 |
| Forward PE | n/a |
| Dividend | 3.50 (5.76%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 3,160,206 |
| Open | 59.02 |
| Previous Close | 58.25 |
| Day's Range | 58.55 - 62.00 |
| 52-Week Range | 56.11 - 93.99 |
| Beta | 0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 3, 2026 |